Keros Therapeutics (KROS) Share-based Compensation (2019 - 2025)
Keros Therapeutics' Share-based Compensation was $7.31 million in Q4 2025, down 20.6% from $9.2 million a year earlier but up 83.3% from the prior quarter.
Powered by 
Analysis
Keros Therapeutics (KROS) Share-based Compensation (2019 - 2025) Analysis & Trends
For FY2025, Share-based Compensation at Keros Therapeutics came in at $28.7 million, down 17.7% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 47.6% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $34.87 million in FY2024 (+21.2%), $28.76 million in FY2023 (+54.0%), $18.68 million in FY2022 (+59.4%) and $11.72 million in FY2021 (+186.1%).
- Quarterly Share-based Compensation has moved between $2.49 million (Q1 2021) and $9.2 million (Q4 2024) over five years.
- Compared with a year earlier, Share-based Compensation has declined for three straight quarters, with growth averaging 3.1% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2021 (growth of 150.1%); the worst was Q3 2025 (a decline of 54.8%).
- Per Business Quant data, KROS's Share-based Compensation in the three quarters before Q4 2025 was $3.99 million (Q3 2025), $8.54 million (Q2 2025) and $8.86 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Keros Therapeutics | 220.97 Mn | -1.71 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.31 Mn |
| Sep 30, 2025 | 3.99 Mn |
| Jun 30, 2025 | 8.54 Mn |
| Mar 31, 2025 | 8.86 Mn |
| Dec 31, 2024 | 9.20 Mn |
| Sep 30, 2024 | 8.82 Mn |
| Jun 30, 2024 | 8.79 Mn |
| Mar 31, 2024 | 8.07 Mn |
| Dec 31, 2023 | 7.32 Mn |
| Sep 30, 2023 | 8.71 Mn |
| Jun 30, 2023 | 7.04 Mn |
| Mar 31, 2023 | 5.69 Mn |
| Dec 31, 2022 | 4.75 Mn |
| Sep 30, 2022 | 4.75 Mn |
| Jun 30, 2022 | 4.79 Mn |
| Mar 31, 2022 | 4.39 Mn |
| Dec 31, 2021 | 3.30 Mn |
| Sep 30, 2021 | 3.08 Mn |
| Jun 30, 2021 | 2.85 Mn |
| Mar 31, 2021 | 2.49 Mn |
API Access
Keros Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();